News

Vanderbilt awarded up to $46M through ARPA-H to develop tools against alphaviruses

Mar. 4, 2025—Vanderbilt University will receive up to $46 million in funding from the Advanced Research Projects Agency for Health to spearhead the development of a vaccine that could protect against all alphaviruses. Jens Meiler, Distinguished Research Professor of Chemistry, was named the principal investigator for the project, in cooperation with 14 investigators across eight institutions. The team will...

LISTEN: ‘Quantum Potential’ podcast episode three featuring Brian Bachmann, professor of chemistry

Mar. 4, 2025— Chemist Brian Bachmann, who is the principal investigator for the Vanderbilt Laboratory for Biosynthetic Studies, envisions a near future where each cancer case is managed individually, moving beyond the traditional approach of location-based treatments. Listen to the episode to learn why “conjugal lagoons,” “molecular choreography” and “stealing IP from molecules” will help make his...